EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 180 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 2.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $236,000 | +3.5% | 4,774 | +6.6% | 0.00% | – |
| Q4 2021 | $228,000 | -4.6% | 4,477 | +4.5% | 0.00% | – |
| Q3 2021 | $239,000 | -29.7% | 4,285 | -47.4% | 0.00% | -100.0% |
| Q1 2021 | $340,000 | +0.3% | 8,139 | +11.9% | 0.00% | 0.0% |
| Q4 2020 | $339,000 | +10.4% | 7,271 | +0.6% | 0.00% | 0.0% |
| Q3 2020 | $307,000 | -12.3% | 7,227 | -1.0% | 0.00% | 0.0% |
| Q2 2020 | $350,000 | -7.9% | 7,298 | -11.7% | 0.00% | 0.0% |
| Q1 2020 | $380,000 | -52.9% | 8,266 | -38.5% | 0.00% | -50.0% |
| Q4 2019 | $807,000 | +7.3% | 13,437 | +1.0% | 0.00% | 0.0% |
| Q3 2019 | $752,000 | +53.2% | 13,302 | +50.7% | 0.00% | +100.0% |
| Q2 2019 | $491,000 | +127.3% | 8,825 | +106.3% | 0.00% | – |
| Q1 2019 | $216,000 | -22.6% | 4,278 | +6.2% | 0.00% | -100.0% |
| Q3 2018 | $279,000 | -8.5% | 4,030 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $305,000 | +21.5% | 4,030 | -4.1% | 0.00% | 0.0% |
| Q3 2017 | $251,000 | -24.4% | 4,204 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $332,000 | +13.3% | 4,204 | +19.1% | 0.00% | 0.0% |
| Q1 2017 | $293,000 | +4.6% | 3,529 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $280,000 | -3.1% | 3,529 | -14.4% | 0.00% | 0.0% |
| Q3 2016 | $289,000 | -8.5% | 4,122 | +15.5% | 0.00% | 0.0% |
| Q4 2015 | $316,000 | +19.7% | 3,568 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $264,000 | -21.7% | 3,568 | -14.5% | 0.00% | 0.0% |
| Q2 2015 | $337,000 | – | 4,171 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 3,652,284 | $302,920,000 | 91.10% |
| Hudson Executive Capital LP | 1,901,200 | $157,686,000 | 21.62% |
| JW Asset Management, LLC | 525,755 | $43,606,000 | 9.08% |
| Cormorant Asset Management, LP | 200,000 | $16,588,000 | 2.41% |
| Park West Asset Management LLC | 488,128 | $40,485,000 | 2.36% |
| Opaleye Management Inc. | 50,000 | $4,147,000 | 2.06% |
| Ranger Investment Management | 283,954 | $23,551,000 | 1.71% |
| Pier Capital, LLC | 74,732 | $6,198,000 | 1.06% |
| Bellevue Group AG | 67,700 | $5,615,000 | 0.75% |
| Orbimed Advisors | 671,000 | $55,653,000 | 0.63% |